Australia markets closed

Medical Developments International Limited (MDDVF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.55000.0000 (0.00%)
At close: 10:30AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 31.40M
Enterprise value 22.78M
Trailing P/E 1.13k
Forward P/E 135.14
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.19
Price/book (mrq)0.97
Enterprise value/revenue 0.68
Enterprise value/EBITDA -1.10

Trading information

Stock price history

Beta (5Y monthly) 1.61
52-week change 3-16.18%
S&P500 52-week change 321.08%
52-week high 30.7065
52-week low 30.4693
50-day moving average 30.5577
200-day moving average 30.5496

Share statistics

Avg vol (3-month) 3108
Avg vol (10-day) 3N/A
Shares outstanding 586.31M
Implied shares outstanding 687.87M
Float 870.1M
% held by insiders 117.75%
% held by institutions 117.41%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 404 Sept 2013
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in AUD.

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -57.27%
Operating margin (ttm)-77.96%

Management effectiveness

Return on assets (ttm)-13.86%
Return on equity (ttm)-23.42%

Income statement

Revenue (ttm)33.55M
Revenue per share (ttm)0.39
Quarterly revenue growth (yoy)8.70%
Gross profit (ttm)N/A
EBITDA -20.83M
Net income avi to common (ttm)-19.21M
Diluted EPS (ttm)-0.1500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)15.7M
Total cash per share (mrq)0.18
Total debt (mrq)2.43M
Total debt/equity (mrq)3.20%
Current ratio (mrq)2.78
Book value per share (mrq)0.88

Cash flow statement

Operating cash flow (ttm)-14.74M
Levered free cash flow (ttm)-12.79M